A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
about
Identifying the Role of E2 Domains on Alphavirus Neutralization and Protective Immune ResponsesPrime-boost immunization strategies against Chikungunya virusChikungunya vaccines in developmentThe Global Virus Network: Challenging chikungunyaPlant expression systems, a budding way to confront chikungunya and Zika in developing countries?Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainDevelopment of Vaccines for Chikungunya Fever.A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.Approaches to the treatment of disease induced by chikungunya virus.A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.RNA-based viral vectors.Chikungunya fever: an emerging viral infection threatening North America and Europe.Chikungunya Virus Vaccines: Viral Vector-Based Approaches.Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species.Vaccine and Therapeutic Options To Control Chikungunya Virus.Comparative Characterization of the Sindbis Virus Proteome from Mammalian and Invertebrate Hosts Identifies nsP2 as a Component of the Virus Nucleocapsid and Sorting Nexin 5 as a Significant Host Factor for Alphavirus Replication.Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approachCellular and Molecular Immune Response to Chikungunya Virus Infection
P2860
Q24701741-F684987D-911E-413D-BEB3-4DE7B1199442Q24701774-92323209-B6B4-4EC9-814B-85B7D8CECBD4Q26700081-55C8E483-21C6-4D2B-BFC8-D22F721FB5CCQ26700155-4474FB27-6DAE-46F9-B740-77DAF2EEF8BEQ26740530-0BBC98D2-0A8F-439E-B22A-3087BBFBF5D5Q28223031-233318DF-C59C-4013-A18D-BBFEC3515A6BQ30240191-188FB7D8-C517-4AB5-9ED3-61CB4E9AE0B5Q30370147-15EFF46A-52A9-479B-A159-5D8C623E90E9Q35238179-1A626DEC-8C39-4EC8-88BE-012BE241EAF8Q37065242-F413C925-2FA6-4AA7-8971-D63C21D5E0F6Q37265013-15A9125E-4C77-470C-BA60-D50CB9F9BCE8Q37427047-89D2E8AA-1853-4E73-8786-7DCF23822955Q37592380-69388951-DA3A-496B-A960-2A673FA49F2AQ37643733-83F26B2B-2AC7-4F1E-95BA-75DE2912BB0BQ38266413-53555F2B-79A1-4228-9165-DCBCBE24F4D6Q38964360-2C1788D3-0489-47C1-87F6-87C0623D0683Q39128566-EEF71213-559A-44D5-A282-B4D6E7A1B554Q39294255-44E5AEC4-547A-4FDA-AAC1-CCEF8DDD9D71Q46247851-3998A421-54CF-42DE-9092-13607F6276F6Q47566099-CB171B39-A956-4F0D-9792-8C8C2D90B5E6Q54216776-01EDF617-249C-4A72-A3CA-82DC02980B01Q58111653-C825FB3E-8D32-43FA-A9DC-469DA765E684Q58575620-6550D5E4-D972-4880-AB1D-9F50DBED474B
P2860
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
@ast
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
@en
type
label
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
@ast
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
@en
prefLabel
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
@ast
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
@en
P2093
P2860
P356
P1433
P1476
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine
@en
P2093
Anasuya Chattopadhyay
John K Rose
Robert Seymour
P2860
P304
P356
10.1128/JVI.01860-12
P407
P577
2012-10-17T00:00:00Z